Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion type Assertion NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_head.
- NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_provenance.
- NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion evidence source_evidence_literature NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_provenance.
- NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion SIO_000772 22587513 NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_provenance.
- NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion wasDerivedFrom befree-20140225 NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_provenance.
- NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion wasGeneratedBy ECO_0000203 NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_provenance.